HPV 16 and 18 compromise the physiological control of the cell cycle by continuous expression of E6 and E7 genes and by binding the related oncoproteins to the tumor suppressor gene products p53 and pRB in anogenital tumors, especially carcinomas of the cervix uteri [23]. Here, TP53 is linked to cervical carcinoma.